Effectiveness of Pneumococcal Vaccines - FPIN's Help Desk Answers - American Family ...
May 1, 2018 - The 23-valent pneumococcal polysaccharide vaccine (PPSV23; Pneumovax 23) decreases the relative risk of community-acquired pneumonia in adults by 13%. The risk is reduced by 28% in the population that includes adults older than 65 years, those with lung disease, and those living in a ...
American Family Physician : FPIN's Help Desk Answers
https://www.aafp.org/afp/2018/0501/od3.html
Pneumococcal Vaccines in Chronic Obstructive Pulmonary Disease - Medicine by the ...
Apr 1, 2018 - Pneumococcal vaccines had no significant effect on mortality from cardiorespiratory disease when compared with control and had no significant effect on all-cause mortality. Find out more.
American Family Physician : Medicine by the Numbers
https://www.aafp.org/afp/2018/0401/p463.html
Shared Decision-Making for Administering PCV13 in Older Adults - Editorials - American ...
Feb 1, 2020 - In June 2019, the Advisory Committee on Immunization Practices approved a change from its age-based 13-valent pneumococcal conjugate vaccine recommendations to a shared clinical decision-making process.
American Family Physician : Editorials
https://www.aafp.org/afp/2020/0201/p134.html
navigate_before 1 navigate_next